Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia

被引：3
作者：
Ercaliskan, Abdulkadir [1 ]
Eskazan, Ahmet Emre [1 ]
机构：
[1] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Div Hematol, Dept Internal Med, TR-34303 Istanbul, Turkey
来源：
FUTURE ONCOLOGY | 2020年 / 16卷 / 03期
关键词：
adverse event; bosutinib; chronic myeloid leukemia; comorbidity; imatinib; tyrosine kinase inhibitor; KINASE INHIBITOR TKI; IMATINIB; DASATINIB; DISCONTINUATION; NILOTINIB; THERAPY; CML;
D O I：
10.2217/fon-2020-0006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4425 / 4428
页数：4
相关论文
共 50 条
  • [41] Practical management of toxicities associated with bosutinib in patients with Philadelphia chromosome-positive chronic myeloid leukemia
    Khoury, H. J.
    Gambacorti-Passerini, C.
    Bruemmendorf, T. H.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 578 - 587
  • [42] Selecting the Best Frontline Treatment in Chronic Myeloid Leukemia
    Yilmaz, Musa
    Abaza, Yasmin
    Jabbour, Elias
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2015, 10 (02) : 145 - 157
  • [43] Tailored tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) based on current evidence
    Ciftciler, R.
    Haznedaroglu, I. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (24) : 7787 - 7798
  • [44] Clinical Trials in Chronic Myeloid Leukemia
    Saussele, Susanne
    Pfirrmann, Markus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (02) : 109 - 115
  • [45] Dasatinib Dose Management for the Treatment of Chronic Myeloid Leukemia
    Talpaz, Moshe
    Saglio, Giuseppe
    Atallah, Ehab
    Rousselot, Philippe
    CANCER, 2018, 124 (08) : 1660 - 1672
  • [46] Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
    Rabian, Florence
    Lengline, Etienne
    Rea, Delphine
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 492 - 500
  • [47] Dasatinib for the treatment of chronic myeloid leukemia
    Fullmer, Amber
    Kantarjian, Hagop
    Cortes, Jorge
    Jabbour, Elias
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (03) : 253 - 260
  • [48] Advances in the treatment of chronic myeloid leukemia
    Anna M Eiring
    Jamshid S Khorashad
    Kimberly Morley
    Michael W Deininger
    BMC Medicine, 9
  • [49] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
    Tiribelli, Mario
    Eskazan, Ahmet Emre
    ONCOLOGY AND THERAPY, 2019, 7 (02) : 95 - 100
  • [50] Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
    Rosshandler, Yasmin
    Shen, Ann Q.
    Cortes, Jorge
    Khoury, Hanna Jean
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (05) : 419 - 424
12345